TransCode Therapeutics, Inc.
RNAZ
$0.38
-$0.02-5.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.81M | 1.88M | 3.35M | 4.91M | 2.77M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 342.30K | 529.40K | 98.10K | 316.70K | 547.70K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 940.00K | 1.21M | 933.70K | 1.48M | 1.14M |
| Total Current Assets | 7.09M | 3.61M | 4.39M | 6.71M | 4.46M |
|
|
|||||
| Total Current Assets | 7.09M | 3.61M | 4.39M | 6.71M | 4.46M |
| Net Property, Plant & Equipment | 89.30K | 211.70K | 326.30K | 464.60K | 602.40K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 111.90K | 111.90K | 111.90K | 111.90K | 111.90K |
| Total Assets | 7.29M | 3.94M | 4.82M | 7.29M | 5.17M |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 2.71M | 2.13M | 3.28M | 2.37M | 3.05M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 38.30K | 152.50K | 227.20K | 339.40K | 412.30K |
| Total Finance Division Other Current Liabilities | 25.40K | -- | -- | -- | 27.10K |
| Total Other Current Liabilities | 25.40K | -- | -- | -- | 27.10K |
| Total Current Liabilities | 2.77M | 2.28M | 3.50M | 2.71M | 3.49M |
|
|
|||||
| Total Current Liabilities | 2.77M | 2.28M | 3.50M | 2.71M | 3.49M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | 38.30K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.54M | -- | -- | -- | -- |
| Total Liabilities | 9.31M | 2.28M | 3.50M | 2.71M | 3.53M |
|
|
|||||
| Common Stock & APIC | 61.18M | 58.91M | 56.26M | 54.33M | 48.06M |
| Retained Earnings | -63.20M | -57.26M | -54.93M | -49.74M | -46.42M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -2.02M | 1.65M | 1.32M | 4.58M | 1.64M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.02M | 1.65M | 1.32M | 4.58M | 1.64M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.02M | 1.65M | 1.32M | 4.58M | 1.64M |
|
|
|||||